Estrone

3-Hydroxyestra-1,3,5(10)-trien-17-one; Estrone; Estrogens conjugated Imp. I (EP); Estradiol Hemihydrate Imp. A (EP); Estriol Imp. B (EP); Ethinylestradiol Imp. C (EP); Estradiol Imp. A (EP); (+)-Estrone; (8R,9S,13S,14S)-3-Hydroxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17H-cyclopenta[a]phenanthren-17-one; 1,3,5(10)-Estratrien-3-ol-17-one; 3-Hydroxy-17-keto-estra-1,3,5-triene; 3-Hydroxyestra-1,3,5(10)-triene-17-one; 3-Hydroxyoestra-1,3,5(10)-trien-17-one; Aquacrine; Crinovaryl; Cristallovar; Crystogen; Destrone; Disynformon; Endofolliculina; Estron; Estrovarin; Estrugenone; Estrusol; Femestrone Inj.; Femestrone injection; Femidyn; Fermidyn; Folikrin; Folipex; Folisan; Follestrine; Follestrol; Follicular hormone; Folliculin; Folliculin (steroid); Folliculinum; Follicunodis; Follidrin; Glandubolin; Hiestrone; Hormofollin; Hormovarine; Kestrone; Ketodestrin; Ketohydroxyestrin; Kolpon; Menagen; Menformon; NSC 9699; Oestrin; Oestroform; Oestrone; Oestroperos; Ovifollin; Perlatan; Solliculin; Theelin; Thelestrin; Thelykinin; Thynestron; Tokokin; Unden; WAY 164397; Wynestron; Delta1,3,5(10)-Estratrien-3-ol-17-one; Estradiol Hemihydrate Impurity A; Estriol Impurity B; Estrogens conjugated Impurity I; Ethinylestradiol Impurity C; Estradiol Impurity A

53-16-7

Suspected of causing cancer

C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O

C18 H22 O2

270.37

InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1

IUPAC name: (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one

Room Temperature

+4°C

API standards; Pharmaceutical and veterinary compounds and metabolites; Pharmaceutical and veterinary compounds and metabolites

https://www.lgcstandards.com/CA/en/p/TRC-E889050-10G

false